Jeffrey Yu - 07 Nov 2023 Form 3 Insider Report for OneMedNet Corp (ONMD)

Role: Chief Medical Officer, Director
Signature: /s/ Robert Golden, Attorney-in-Fact
Issuer symbol: ONMD
Transactions as of: 07 Nov 2023
Transactions value $: $0
Form type: 3
Filing time: 26 Nov 2025, 21:49:34 UTC
Next filing: 26 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Yu Jeffrey	Chief Medical Officer, Director	6385 OLD SHADY OAK ROAD,, SUITE 250, EDEN PRAIRIE	/s/ Robert Golden, Attorney-in-Fact	26 Nov 2025	0001991132

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ONMD	Common Stock						2.46M	07 Nov 2023	Direct
holding	ONMD	Common Stock						1.31M	07 Nov 2023	By trust for children	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ONMD	Senior Secured Convertible Note							07 Nov 2023	Common Stock	$532K	$10.00	Direct	F2
holding	ONMD	Warrants (Right to Buy)							07 Nov 2023	Common Stock	31.9K	$10.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.
F2	On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes.
F3	The warrants are immediately exercisable, and the exercise price is subject to anti-dilution adjustment.

Remarks:

Exhibit 24 - POWER OF ATTORNEY